Loading…
Underlying
Underlying Price
$38.90
Type
Call
Strike
20
Expiration
Jan 19, 2029
DTE
818d
Moneyness
ITM
Intrinsic
$18.90
NVO 20 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Dec 18, 2026 | 55d | $18.59 | -0.05% | 1 | 18 |
| Jan 15, 2027 | 83d | $18.76 | +5.75% | 1 | 159 |
| Mar 19, 2027 | 146d | $19.40 | +1.31% | 10 | 61 |
| Jun 17, 2027 | 236d | $20.03 | +5.14% | 1 | 698 |
| Sep 17, 2027 | 328d | $20.12 | +0.10% | 1 | 20 |
| Dec 17, 2027 | 419d | $19.90 | +3.11% | 1 | 78 |
| Jan 21, 2028 | 454d | $20.15 | +0.50% | 1 | 885 |
| Jun 16, 2028 | 601d | $20.45 | +0.99% | 147 | 601 |
| Dec 15, 2028 | 783d | $20.50 | +0.15% | 1 | 56 |
| Jan 19, 2029 | 818d | $20.83 | +1.86% | 3 | 81 |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.